向细胞内癌症蛋白与瘤微环境响应的双特异纳米体-PROTAC,以提高治疗疗效
Changping Deng1,2, Jiacheng Ma3, Yuping Liu4
1State Key Laboratory of Bioreactor Engineering East China University of Science and Technology Shanghai P. R. China.
MedComm
|January 20, 2025
概括
我们开发了BumPeD,这是一种新的癌症治疗平台,使用纳米体和瘤微环境精确降解瘤蛋白质. 这种有针对性的方法提高了疗效,降低了毒性,改善了癌症治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 针对蛋白质溶解的嵌合体 (PROTACs) 提供针对癌症治疗的向蛋白质降解.
- 传统的PROTACs的非特异性可能会导致正常细胞的全身毒性.
- 利用瘤微环境可以增强药物特异性.
研究的目的:
- 为了设计一种新的双特异的纳米体向的PROTACs类平台,命名为BumPeD.
- 为了利用瘤微环境对细胞内蛋白质降解进行定向.
- 评估BumPeD在向PD-L1和癌症治疗的细胞内幸存者的有效性.
主要方法:
- 通过将纳米体与富林蛋白质酶裂解部位和降解序列融合而设计的BumPeD.
- 利用KN035和Nb4A纳米体来准细胞表面PD-L1和细胞内生存.
- 进行了体外和体内实验,以评估蛋白质降解,亡和抗瘤作用.
主要成果:
- 在体外,BumPeD成功地通过ubiquitin-proteasome途径触发了Survivin的降解.
- 已证明诱导瘤亡和抑制膀瘤细胞的增殖和迁移.
- 在体内确认了强大的抗瘤疗效,突出了精确的蛋白质降解潜力.
结论:
- BumPeD代表了用于癌症治疗的精确蛋白质降解策略.
- 该平台提供了一种系统的方法来开发有效和实用的降解药物.
- 为新型癌症疗法提供了有针对性的理论基础和实验支持.
更多相关视频
08:09Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
Published on: April 6, 2015
11.6K
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.5K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
468
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
